MINISTRY OF HEALTH AND WELFARE Notice is hereby given, to commence a period of public comments for drafting the implementing pharmaceuticals and the types of pharmaceutical firms, requirement, methods and schedules for "Western Pharmaceuticals Good Distribution Practice Regulations" - active pharmaceutical ingredients
MINISTRY OF HEALTH AND WELFARE Notice is hereby given, for the promulgation of the implementation of pharmaceuticals and the types of pharmaceutical firms, requirement, methods and schedules regulated under "Western Pharmaceuticals Good Distribution Practice Regulations"-active pharmaceutical ingredients (promulgation becomes effective from 27th, July 2020)
機關綜整回應
衛生福利部食品藥物管理署2020-07-27
綜整回應
一、原料藥標示之儲存溫度(如Room Temperature、cold or cool),係依據藥品查驗登記之安定性試驗結果定之,且溫度之定義係依據各國藥典規定,藥商本應依據所標示之溫度條件予以儲運。